Hyperlipidemia in chronic hepatitis C under triple therapy with boceprevir

被引：0
|
作者：
Mata-Marin, J. [1 ]
Huerta-Garcia, G. [2 ]
Manjarrez-Tellez, B. [1 ]
Andrade-Fuentes, K. [3 ]
Sandoval-Ramirez, J. [1 ]
Martiinez-Rodriguez, M. [1 ]
机构：
[1] Hosp Infectol, Mexico City, DF, Mexico
[2] Hosp Pediat Mexico City, Mexico City, DF, Mexico
[3] Hosp Especialidades Ctr Med La Raza, Mexico City, DF, Mexico
来源：
JOURNAL OF VIRAL HEPATITIS | 2014年 / 21卷
关键词：
D O I：
10.1111/jvh.12333_25
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P26
引用
收藏
页码：35 / 36
页数：4
相关论文
共 50 条
  • [1] Renal impairment is frequent in chronic hepatitis C patients under triple therapy with telaprevir or boceprevir
    Mauss, Stefan
    Eisenbach, Christoph
    Heyne, Renate
    Moog, Gero
    Lutz, Thomas
    Naumann, Uwe
    Geissler, Michael
    Pape, Stefan
    Mordeja, Matthias
    Herold, Christoph
    Simon, Karl-Georg
    Isernhagen, Konrad
    Alshuth, Ulrich
    Buggisch, Peter
    Hueppe, Dietrich
    HEPATOLOGY, 2013, 58 : 1112A - 1112A
  • [2] Renal Impairment Is Frequent in Chronic Hepatitis C Patients Under Triple Therapy With Telaprevir or Boceprevir
    Mauss, Stefan
    Hueppe, Dietrich
    Alshuth, Ulrich
    HEPATOLOGY, 2014, 59 (01) : 46 - 48
  • [3] Renal Impairment Is Frequent in Chronic Hepatitis C Patients Under Triple Therapy With Telaprevir or Boceprevir
    Loustaud-Ratti, Veronique
    Carrier, Paul
    Vong, Chanlina
    Essig, Marie
    HEPATOLOGY, 2014, 59 (06) : 2426 - 2426
  • [4] Renal Impairment Is Frequent in Chronic Hepatitis C Patients Under Triple Therapy With Telaprevir or Boceprevir Reply
    Gordon, Stuart C.
    Yee, Leland J.
    Martins, Eduardo Bruno
    HEPATOLOGY, 2014, 59 (06) : 2427 - 2427
  • [5] Effectiveness of telaprevir/boceprevir-based triple therapy for chronic hepatitis c
    Garcia-Queiruga, Marta
    Purificacion, Cid
    Laura Maria, Martinez-Lopez
    Marta, Leston
    Luis, Margusino
    Isabel, Martin
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2015, 37 (01) : 280 - 281
  • [6] Telaprevir or boceprevir triple therapy in patients with chronic hepatitis C and varying severity of cirrhosis
    Saxena, V.
    Manos, M. M.
    Yee, H. S.
    Catalli, L.
    Wayne, E.
    Murphy, R. C.
    Shvachko, V. A.
    Pauly, M. P.
    Chua, J.
    Monto, A.
    Terrault, N. A.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2014, 39 (10) : 1213 - 1224
  • [7] Treatment of chronic hepatitis C genotype 1 with triple therapy comprising telaprevir or boceprevir
    Moradpour, Darius
    Muellhaupt, Beat
    SWISS MEDICAL WEEKLY, 2012, 142
  • [8] A Small Percentage of Patients With Hepatitis C Receive Triple Therapy With Boceprevir or Telaprevir
    Chen, Emerson Y.
    Sclair, Seth N.
    Czul, Frank
    Apica, Betty
    Dubin, Perry
    Martin, Paul
    Lee, William M.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2013, 11 (08) : 1014 - +
  • [9] Boceprevir and Treatment of Chronic Hepatitis C
    Kwo, Paul Y.
    CLINICS IN LIVER DISEASE, 2013, 17 (01) : 63 - +
  • [10] Effectiveness of Triple Therapy With Boceprevir, Pegylated Interferon, and Ribavirin in Veteran Patients With Chronic Hepatitis C Virus Infection
    Andrade, Christian
    Patel, Brijesh
    Muhammad, Adnan
    Vidyarthi, Gitanjali
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2014, 109 : S178 - S178
12345